|
NAALADL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.965000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.528400E-01 |
| Normal-vs-Stage2 |
1.693570E-01 |
| Normal-vs-Stage3 |
8.228400E-01 |
| Normal-vs-Stage4 |
2.724200E-01 |
| Stage1-vs-Stage2 |
6.020200E-02 |
| Stage1-vs-Stage3 |
7.617000E-01 |
| Stage1-vs-Stage4 |
4.094200E-01 |
| Stage2-vs-Stage3 |
1.345840E-01 |
| Stage2-vs-Stage4 |
5.023700E-02 |
| Stage3-vs-Stage4 |
3.489400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.561800E-01 |
| Normal-vs-AfricanAmerican |
3.228400E-02 |
| Normal-vs-Asian |
1.783390E-01 |
| Caucasian-vs-AfricanAmerican |
3.412000E-02 |
| Caucasian-vs-Asian |
1.627920E-02 |
| AfricanAmerican-vs-Asian |
6.983100E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.386600E-01 |
| Normal-vs-Female |
5.094200E-01 |
| Male-vs-Female |
5.754200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.782000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.133600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.330600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.163400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.332200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.099000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.732800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.218200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.322770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.655800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.720800E-01 |
| Classical-VS-Follicular |
5.44930001122879E-09 |
| Classical-VS-Other |
6.092800E-01 |
| Classical-VS-Normal |
5.855700E-02 |
| Tall-VS-Follicular |
2.003800E-04 |
| Tall-VS-Other |
5.065600E-01 |
| Tall-VS-Normal |
1.540590E-01 |
| Follicular-VS-Other |
1.536000E-01 |
| Follicular-VS-Normal |
9.405700E-04 |
| Other-VS-Normal |
9.479800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.286800E-01 |
| Normal-vs-N1 |
9.812400E-01 |
| N0-vs-N1 |
4.663200E-01 |
|
|
